Status:
RECRUITING
Early Detection of Type 1 Diabetes
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
1-18 years
Brief Summary
T1D is an autoimmune disease characterized by the presence of autoantibodies usually assayed separately on venous blood. The use of a combined test on capillary blood using a blotting paper would faci...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Children aged over 1 year and under 18 years
- BMI \<30.0 kg/m2
- With a diagnosis of stage 3 type 1 diabetes (clinical and laboratory criteria, metabolic acidosis, ketone levels)
- Child's consent and no parental opposition Exclusion criteria
- Patients with T2D or monogenic diabetes with a known familial history
- Patients with cystic fibrosis
- History of liver or kidney disease, or pancreatitis
- Any progressive disease (other than T2D)
Exclusion
Key Trial Info
Start Date :
November 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 5 2026
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06984185
Start Date
November 5 2025
End Date
December 5 2026
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Femme Mère Enfant Hospital, Hospices Civils de Lyon
Bron, Rhône, France, 69500